Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Andrew Bae"'
Autor:
Andrew Bae, Susu Xu
Publikováno v:
Proceedings of the Twentieth ACM Conference on Embedded Networked Sensor Systems.
Autor:
Linda M Sircy, Andrew G Ramstead, Lisa C Gibbs, Hemant Joshi, Andrew Baessler, Ignacio Mena, Adolfo García-Sastre, Lyska L Emerson, Keke C Fairfax, Matthew A Williams, J Scott Hale
Publikováno v:
PLoS Pathogens, Vol 20, Iss 9, p e1011639 (2024)
Current influenza vaccine strategies have yet to overcome significant obstacles, including rapid antigenic drift of seasonal influenza viruses, in generating efficacious long-term humoral immunity. Due to the necessity of germinal center formation in
Externí odkaz:
https://doaj.org/article/67badab4cd554c29b4561222bf73923a
Autor:
Phiroze Sethna, Andrew Bae, Katherine Sortino, Jeffrey M. Chamberlain, Robert A. Bambara, Stephen Dewhurst, Randall Lanier
Publikováno v:
Antimicrobial Agents and Chemotherapy. 63
Human adenovirus (AdV) can cause fatal disease in immune-suppressed individuals, but treatment options are limited, in part because the antiviral cytidine analog cidofovir (CDV) is nephrotoxic. The investigational agent brincidofovir (BCV) is orally
Autor:
Roy F. Chemaly, Janet A. Englund, Gregory E. Chittick, Marion E. Morrison, Andrew Bae, Joanne Kurtzberg, Vinod K. Prasad, Michael Grimley, Thomas M. Brundage
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(3)
Adenovirus infection in immunocompromised patients contributes to significant morbidity and mortality, especially after allogeneic hematopoietic cell transplantation (HCT). Brincidofovir (BCV, CMX001) is an orally bioavailable lipid conjugate of cido
Autor:
Jeanette Harris, Andrew Bae, Hadas Dvory-Sobol, Michael D. Miller, Kelly A. Wong, Hongmei Mo, Phillip S. Pang, Karin S. Ku, Eric Lawitz
Publikováno v:
Antimicrobial Agents and Chemotherapy. 56:5289-5295
GS-9451, a novel hepatitis C virus (HCV) nonstructural 3/4a (NS3/4a) protease inhibitor, is highly active in patients infected with HCV genotype 1 (GT 1). The aim of this study is to characterize the clinical resistance profile of GS-9451 in GT 1 HCV
Autor:
Ayako Suzuki, Ricardo Henao, Andrew Bae, Cynthia D. Guy, Manal F. Abdelmalek, Cynthia A. Moylan, Anna Mae Diehl
Publikováno v:
Gastroenterology. 154:S-1085
Autor:
Jeanette Harris, Xiaoping Qi, Michael I. Miller, Shan Liu, Andrew Bae, William E. Delaney, Siu-Chi Sun, Hongmei Mo, Huiling Yang
Publikováno v:
Antiviral Research. 81:166-173
Hepatitis C virus (HCV) protease inhibitors targeting HCV NS3 can efficiently suppress HCV replication. However, the selection of resistance has been observed both in vitro and in vivo. Here, we describe a new method for efficient analysis of the dru
Autor:
Andrew Bae, Katyna Borroto-Esoda, Lijie Zhong, Nicolas A. Margot, Evguenia S. Svarovskaia, Derrick D. Goodman, Michael D. Miller, Joshua M. Waters
Publikováno v:
JAIDS Journal of Acquired Immune Deficiency Syndromes. 46:174-180
Background: Prior abacavir (ABC) or didanosine (ddI) therapy can result in the L74V/I or K65R mutation in HIV-1 reverse transcriptase. Preexisting K65R may have an impact on the treatment response to tenofovir disoproxil fumarate (TDF). Methods: An a
Autor:
Karin S. Ku, Evguenia S. Svarovskaia, Andrew Bae, Derrick D. Goodman, Hongmei Mo, Michael D. Miller
Publikováno v:
Journal of Antivirals & Antiretrovirals.
Tegobuvir (GSâ9190) is a novel hepatitis C virus (HCV) nonânucleoside NS5B polymerase inhibitor that effectively inhibits HCV replication in HCV-infected genotype (GT) 1 patients. The NS5B Y448H mutation was the most frequent mutation selec
Autor:
Herve Mommeja-Marin, Randall Lanier, Garrett Nichols, Thomas M. Brundage, Andrew Bae, Phiroze Sethna
Publikováno v:
Biology of Blood and Marrow Transplantation. 22:S55